Departamento de Ciencias Médicas Básicas, Facultad de Medicina, IMMA, Universidad San Pablo CEU, CEU Universities, Madrid, Spain.
ARADyAL-RD16/0006/0015 RD16/0006/0003, Thematic Network and Cooperative Research Centers, ISCIII, Madrid, Spain.
Allergy. 2021 Dec;76(12):3642-3658. doi: 10.1111/all.14969. Epub 2021 Jun 22.
Progressive knowledge of allergenic structures resulted in a broad availability of allergenic molecules for diagnosis. Component-resolved diagnosis allowed a better understanding of patient sensitization patterns, facilitating allergen immunotherapy decisions. In parallel to the discovery of allergenic molecules, there was a progressive development of a regulation framework that affected both in vitro diagnostics and Allergen Immunotherapy products. With a progressive understanding of underlying mechanisms associated to Allergen immunotherapy and an increasing experience of application of molecular diagnosis in daily life, we focus in analyzing the evidences of the value provided by molecular allergology in daily clinical practice, with a focus on Allergen Immunotherapy decisions.
对过敏原结构的深入了解使得大量的过敏原分子可用于诊断。基于成分的诊断方法可以更好地了解患者的致敏模式,从而有助于变应原免疫治疗决策。与过敏原分子的发现并行的是监管框架的逐步发展,这既影响体外诊断又影响变应原免疫治疗产品。随着对变应原免疫治疗相关潜在机制的认识不断深入,以及分子诊断在日常生活中应用经验的不断增加,我们重点分析了分子变态反应学在日常临床实践中提供价值的证据,重点是变应原免疫治疗决策。